Drug-labels.com

PMS-Raloxifene: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
60 mg
Active ingredient:
ATC code:
Similar drugs:

Patient Medication Information: uses, side effects, how to take - PMS-Raloxifene

ABOUT THIS MEDICATION

What pms-RALOXIFENE is used for:

pms-RALOXIFENE is used to treat or to prevent osteoporosis in postmenopausal women.

What is Osteoporosis?

Osteoporosis is a thinning and weakening of the bones making the bones more likely to break. It is common in women after menopause or after removal of the ovaries because of the decrease in estrogens. A variety of risk factors may promote osteoporosis. These include:

  • Caucasian or Asian descent
  • Slender build
  • Early menopause
  • Smoking
  • Drinking alcohol
  • A diet low in calcium
  • Lack of exercise
  • A family history of osteoporosis

The greater the number of risk factors, the greater the probability of developing osteoporosis.

Initially osteoporosis usually does not cause any symptoms, but if left untreated may result in fractures. While most fractures are painful, fractures of the spine may not be noticed until they result in loss of height or a stooped posture. The fractures may occur as the result of normal every day activity or from minor injuries, which would ordinarily not result in broken bone.

How can osteoporosis be prevented or treated?

  • Eat a balanced diet. Vitamin D and calcium are necessary for

    building strong bones. The requirement for vitamin D increases as you grow older. In the winter, when there is less sunlight, your skin produces less vitamin D. Discuss with your doctor the need to take vitamin D and calcium supplements.

  • Do not smoke.
  • Exercise. Bones need exercise to stay strong and healthy. Consult

    your doctor about an exercise program suitable to you.

  • While diet, exercise and vitamins are essential to good health, they

    may not be enough to offset the effects of estrogen decline in some women's bodies after menopause. Consequently, some people may require medications such as pms-RALOXIFENE to prevent or treat osteoporosis.

What pms-RALOXIFENE does:

pms-RALOXIFENE is a Selective Estrogen Receptor Modulator or SERM. pms-RALOXIFENE is not a hormone, but it acts like estrogen in

some parts of your body including the bones, but not like estrogen in other parts of the body. In the bones it promotes the building of new bone, either to prevent or treat osteoporosis.

When pms-RALOXIFENE should not be used:

Do not take pms-RALOXIFENE if:

  • you have not passed menopause. pms-RALOXIFENE is for use only by women after menopause.
  • you are pregnant or could become pregnant. pms-RALOXIFENE could harm your unborn child.

  • you are nursing a baby. It is not known if pms-RALOXIFENE passes into breast milk or what effect it might have on the baby.
  • you have or have had blood clots in the veins that required a doctor's treatment. This may include clots in the legs, lungs or eyes. Taking pms-RALOXIFENE may increase the risk of getting these blood clots.
  • you are allergic to raloxifene or any of the other ingredients in pms-

    RALOXIFENE listed in the "nonmedicinal ingredients" section below.

What the medicinal ingredient is:

raloxifene hydrochloride

What the important nonmedicinal ingredients are:

citric acid, dibasic calcium phosphate, hydroxypropyl methylcellulose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, poloxamer 407, polyethylene glycol, sodium starch glycolate, titanium dioxide.

What dosage form pms-RALOXIFENE comes in:

Tablet 60 mg.

WARNINGS AND PRECAUTIONS

Before starting pms-RALOXIFENE and to get the best possible treatment, be sure to tell your doctor if you:

  • are pregnant, breast feeding, still have menstrual bleeds, or have had a menstrual bleed in the last year, as pms-RALOXIFENE is only for postmenopausal women.
  • have had an allergic reaction to any medicine you have taken.
  • are intolerant to lactose because pms-RALOXIFENE contains lactose.
  • have or ever had liver problems.
  • have or ever had blood clots in the veins. If you take warfarin

    (blood thinner) or other coumarin derivatives, pms-RALOXIFENE may not be suitable for you. pms-RALOXIFENE is contraindicated in women with an active or past history of blood clots in the veins. If you are taking the blood thinners for other reasons your doctor may need to check your prothrombin (blood clotting) time and adjust your medicine when you first begin taking pms-RALOXIFENE.

  • are currently on any other medications, prescription or non prescription.
  • have had a stroke or have a history of other significant risk factors for stroke, such as a "mini-stroke" (TIA/transient ischemic attack), or a type of irregular heartbeat (atrial fibrillation).

Being immobile for a long time can increase the risk of blood clots in the veins. pms-RALOXIFENE may add to this risk. If while taking pms-

RALOXIFENE you plan to be immobile, such as staying in bed after surgery, or taking a long plane trip, you should stop taking pms-RALOXIFENE at least 3 days before, to reduce your risk of blood clots in the veins. When you are back on your feet, you may start taking pms-RALOXIFENE again (see SIDE EFFECTS AND WHAT TO DO ABOUT THEM).

INTERACTIONS WITH THIS MEDICATION

You should always tell your doctor about all drugs that you are taking or plan to take before starting to take pms-RALOXIFENE.

The effect of pms-RALOXIFENE is significantly reduced if taken with cholestyramine (products which contain cholestyramine include Questran®, Questran Light®, Alti-Cholestyramine Light, Novo-Cholamine, Novo-Cholamine Light, PMS-Cholestryramine). Therefore, you should not take cholestyramine while taking pms-RALOXIFENE.

It is not recommended that you combine pms-RALOXIFENE with hormone replacement therapy (ERT or HRT) since safety information is limited and no studies have been done to look at the effectiveness of this combination.

During clinical trials, raloxifene was taken with commonly prescribed medications such as acetaminophen, digoxin, nonsteroidal anti-inflammatory drugs (NSAIDS), and oral antibiotics with no observed problems. However, because each patient is different, you should always check with your doctor before taking any other medication.

PROPER USE OF THIS MEDICATION

Usual dose:

Take one pms-RALOXIFENE 60 mg tablet, once-a-day, any time, with or without food. pms-RALOXIFENE comes in a bottle with 100 tablets and a 30-day blister pack that you start as soon as you fill your prescription. Each day of the week is printed above each tablet to make it easy to check if you've taken your pill that day.

You might find it helpful to take your tablet at the same time every day so that it's simply part of your routine. The efficacy of pms-RALOXIFENE is dependent upon your taking it regularly. Therefore, you should keep taking pms-RALOXIFENE until your doctor advises you otherwise.

Overdose:

If you take too much pms-RALOXIFENE, immediately contact your doctor, go to your nearest hospital emergency department, or contact the Regional Poison Control Centre. Show the doctor your blister pack of tablets. Do this even if there are no signs of discomfort or poisoning.

Missed Dose:

If you miss a day of pms-RALOXIFENE take one pill as soon as you remember and resume one tablet once daily. Do not take two doses at the same time.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

During clinical trials, some women did have mild side effects however most women did not find these side effects serious enough to stop taking pms-RALOXIFENE. The most common side effects of pms-RALOXIFENE are:

  • hot flashes
  • leg cramps

Another common side effect is flu-like symptoms.

Similar to estrogen replacements, pms-RALOXIFENE may increase the risk of blood clots in the veins. Although this is an uncommon side effect, if you experience any of the following unusual symptoms talk to your doctor immediately:

  • redness, swelling, heat or pain in your calves and legs
  • sudden chest pain or shortness of breath
  • a sudden change in your vision

pms-RALOXIFENE is not associated with adverse effects on the uterus, breast, or mental function. Therefore, any unexplained uterine bleeding, breast enlargement, breast pain, change in mood or deterioration of mental function should be reported to your doctor.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmaci st

Only if

severe

In all cases
UncommonBlood clots in the veins*T
RareBlood clots in the lungs*T
Rare

Stroke

fatality**

* See "SIDE EFFECTS AND WHAT TO DO ABOUT THEM" for symptoms of blood clots in the veins. If you experience any of the listed symptoms talk to your doctor immediately.

** Women who have had a heart attack or are at risk for a heart attack may have an increased risk of dying from stroke when taking pms-RALOXIFENE.

This is not a complete list of side effects. For any unexpected effects while taking pms-RALOXIFENE, contact your doctor or pharmacist.

HOW TO STORE IT

All medicines should be stored out of the reach of children. pms-RALOXIFENE should be stored at room temperature (between 15 to 30°C).

REPORTING SUSPECTED SIDE EFFECTS You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

$ Report online at www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345

$ Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program Health Canada

    Postal Locator 0701D

    Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect .

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals, can be obtained by contacting the sponsor, Pharmascience Inc. at, 1-888-550-6060.

Pharmascience Inc.

Montreal Quebec

H4P 2T4

Last revised: August 03, 2011

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02358921

Revision date stated in the text: August 3, 2011

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for PMS-Raloxifene

Rx or OTC
Prescription (Rx)?
DIN 02358921
Schedule(s) PRESCRIPTION
Active ingredient(s) Raloxifene hydrochloride 60 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. G Genito urinary system and sex hormones
    1. G03 Sex hormones and modulators of the genital system
      1. G03X Other sex hormones and modulators of the genital system
        1. G03XC Selective estrogen receptor modulators
          1. G03XC01 Raloxifene
Company PHARMASCIENCE INC
Current status Cancelled Post Market
Current status date April 22, 2020

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.